Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,308 | 4,008 | 3,860 | 5,571 | 7,336 |
| Receivables | 6 | 5 | 13 | 19 | 25 |
| Other current assets | 114 | 106 | 91 | 24 | 8 |
| TOTAL | $2,855 | $4,319 | $4,080 | $5,972 | $7,945 |
| Non-Current Assets | |||||
| PPE Net | 5 | 5 | 6 | 4 | 5 |
| Other Non-Current Assets | 2 | 2 | 2 | 2 | 4 |
| TOTAL | $7 | $7 | $8 | $6 | $9 |
| Total Assets | $2,862 | $4,327 | $4,088 | $5,978 | $7,953 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 825 | 651 | 614 | 896 | 1,278 |
| Accrued Expenses | 240 | 937 | 739 | 784 | 562 |
| TOTAL | $1,065 | $1,588 | $1,353 | $1,680 | $1,840 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,065 | $1,588 | $1,353 | $1,680 | $1,840 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,868 | 2,507 | 2,076 | 2,047 | 1,967 |
| Common Shares | 3 | 2 | 2 | 2 | 2 |
| Retained earnings | -41,457 | -38,960 | -35,921 | -33,236 | -29,568 |
| TOTAL | $1,797 | $2,739 | $2,735 | $4,299 | $6,113 |
| Total Liabilities And Equity | $2,862 | $4,327 | $4,088 | $5,978 | $7,953 |